Clinical Trials Browser

INDUSTRY × Melanoma × 1-methyltryptophan × Clear all

NCT02073123 2026-05-29

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

Phase 1/2 Completed

131 enrolled 23 charts

Melanoma

NCT03301636 2022-09-27

NLG2107

Phase 2 Terminated

21 enrolled 11 charts

Melanoma

NCT00739609 2020-05-28

D-1MT

Phase 1 Terminated

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms